Details for 2013730652
Up to date per 04.04.2026
Actions
Details for 2013730652
Granted/Registered
European Patent
22.04.2015 A
21.02.2018 B1
15.05.2012
US
201261647174 P
15.03.2013
US
201361790967 P
C07D 401/14 20060101AFI20131204BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
DODD, Stephanie KayNovartis Institutes for BioMedical Research, Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139US
FURET, PascalNovartis Pharma AG, Werk Klybeck Postfach, 4002 BaselCH
GROTZFELD, Robert MartinNovartis Pharma AG, Forum 1 Novartis Campus, 4056 BaselCH
JONES, Darryl BrynleyNovartis Pharma AG, Forum 1 Novartis Campus, 4056 BaselCH
MANLEY, PaulNovartis Pharma AG, Werk Klybeck Postfach, 4002 BaselCH
MARZINZIK, AndreasNovartis Pharma AG, Werk Klybeck Postfach, 4002 BaselCH
PELLE, Xavier Francois AndreNovartis Pharma AG, Forum 1 Novartis Campus, 4056 BaselCH
SALEM, BahaaNovartis Pharma AG, Werk Klybeck Postfach, 4002 BaselCH
SCHOEPFER, JosephNovartis Pharma AG, Werk Klybeck Postfach, 4002 BaselCH
JAHNKE, WolfgangNovartis Pharma AG, Postfach, 4002 BaselCH
Information about Fees